Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Purity | ≥98% |
---|---|
Formula | C25H39H7O8 |
Formula Wt. | 565.63 |
Synonym | EHIPA. |
Solubility | Soluble in water (2 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Sulforaphane homolog, ITC found in cruciferous ...
Sulfonamide; PABA inhibitor.
Polyphenol found in Gossypium; calcineurin and ...
Aminoglycoside; protein translation inhibitor.<...
Alkaloid found in Corydalis and Stephania; D1/2...
Valosin-containing protein inhibitor.
Mouse selective STING agonist.
Agonist of STING.
EGFR inhibitor.
Synthetic nitrile compound
Hec1/Nek2 mitotic pathway inhibitor
NSAID; COX-2 inhibitor.
Found in Paeonia; L-type Ca2+ channel blocker.<...
MAGL inhibitor.
HDM2 inhibitor
STING antagonist
Thienylbutyl ITC analog.
Endogenous peptide hormone fragment, involved i...
5-α-Reductase inhibitor.